Abstract: Provided are copolycarbonate compositions including a stabilizer package which comprise a phosphorous-containing acid, an ester of phosphorous-containing acid, and an organosulfonic stabilizer where the phosphorous-containing acid and the ester of a phosphorous-containing acid are present in a molar ratio of 1 to 2. The total stabilization package is for example, in the amount by weight of 4 to 32 ppm, 8 to 24 ppm, or 8 to 16 ppm and the organosulfonic stabilizer is, e.g., of 2 to 30 ppm, or 4 to 24 ppm, or 8 to 16 ppm.

Abstract: A medical delivery device comprising an elongate body having a plunger slidably and sealingly engaged to form a cavity to receive fluid materials and a first outlet disposed at an end of said body and has a male luer end portion and a valve assembly is disposed within the first outlet. The valve assembly has a valve means movable between an open position and a closed position and biasing means for biasing the valve means to a closed position. Actuating means are disposed within the male luer end portion and coupled to the valve means such that the valve means is movable to an open position when a female luer end portion of a medical accessory is coupled with the male luer end portion. A second outlet is disposed at the same end as the first outlet for controlling the exchange of gases from the environment to said cavity under the action of the plunger.

Abstract: A device for controlling the collection and delivery of materials to a patient, the device has a dispenser-engaging portion, the dispenser-engaging portion being operable in a release position to receive a materials dispenser when the dispenser is in a materials-containing configuration, the dispenser-engaging portion being operable in a lock condition for locking the dispenser therewith, and access control means for controlling the release and lock positions according to a material transaction condition.

Abstract: A medical delivery device comprising an elongate body having a plunger slidably and sealingly engaged to form a cavity to receive fluid materials and a first outlet disposed at an end of said body and has a male luer end portion and a valve assembly is disposed within the first outlet. The valve assembly has a valve means movable between an open position and a closed position and biasing means for biasing the valve means to a closed position. Actuating means are disposed within the male luer end portion and coupled to the valve means such that the valve means is movable to an open position when a female luer end portion of a medical accessory is coupled with the male luer end portion. A second outlet is disposed at the same end as the first outlet for controlling the exchange of gases from the environment to said cavity under the action of the plunger.

Abstract: Disclosed herein is a system for the collection, treatment and delivery of an autologous blood sample, comprising a first syringe having a first body portion. A first sample transfer portion has a first syringe inlet for drawing an untreated blood sample from a patient and a first syringe outlet for dispensing the untreated blood sample. A blood sample treatment chamber having a chamber inlet, the first syringe outlet being operable to establish a dedicated first fluid coupling with the chamber inlet to dispense the untreated blood sample to the blood sample treatment chamber. The blood sample treatment chamber having a chamber outlet for dispensing a treated blood sample following treatment. The second syringe has a second body portion and a second sample transfer portion, the second sample transfer portion having a passage with a first access location which is operable to form a dedicated second fluid coupling with the chamber outlet.

Abstract: A medical treatment process and system, in which a patient fluid is subjected to extracorporeal handling and treatment prior to administration to the patient, is provided. The system includes two or more treatment units which successively handle the fluid, and a token associated with the patient. The token includes a patient identification and, as the treatment proceeds, more information is added to the token as the fluid moves around the system until the token contains a record of the treatment conducted on the sample, the times of various treatments, and a verification that treatment has been conducted in accordance with pre-determined criteria. The token, provided it contains information verifying the identity of the patient and treatment according to specification, allows administration of the treated fluid to the patient and provides an audit record of the treatment.